GSK Flonase Switch Application Coming? Actual-Use Study Underway
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline is actively considering the switch potential for Flonase with a trial evaluating consumers' ability to use the allergy nasal spray appropriately, according to the firm
You may also be interested in...
Clarinex OTC Option “Valuable” In Face Of Competition – Schering-Plough
The option to file an OTC switch application for Rx Clarinex (desloratadine) is an important part of Schering-Plough's strategy for growth, CEO Fred Hassan said during the firm's fiscal 2006 fourth-quarter earnings call Jan. 29
Clarinex OTC Option “Valuable” In Face Of Competition – Schering-Plough
The option to file an OTC switch application for Rx Clarinex (desloratadine) is an important part of Schering-Plough's strategy for growth, CEO Fred Hassan said during the firm's fiscal 2006 fourth-quarter earnings call Jan. 29
Clarinex OTC Option “Valuable” In Face Of Competition – Schering-Plough
The option to file an OTC switch application for Rx Clarinex (desloratadine) is an important part of Schering-Plough's strategy for growth, CEO Fred Hassan said during the firm's fiscal 2006 fourth-quarter earnings call Jan. 29